Terapias de soporte en la sepsis severa. Surviving Sepsis Campaign 2.012
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
DOI:
https://doi.org/10.30445/rear.v5i11.338Keywords:
hemoderivados, sepsis, shock, Surviving Sepsis, terapia de soporteAbstract
En el año 2012 se ha publicado la última edición de la Surviving Sepsis Campaign. Editada en forma de Guía de Práctica Clínica, consta de dos partes bien diferenciadas. En la primera se presentan todos los aspectos relacionados con el tratamiento específico de la infección, es decir, tratamiento antimicrobiano y control del foco.
También están incluidos los cuidados de reanimación inicial del paciente, es decir, soporte hemodinámico y administración de fluidos. La segunda parte, titulada “Terapia de Soporte en la Sepsis Grave”, aborda el resto de tratamientos y medidas de soporte orgánico general, no específicas de la sepsis, pero que deben ser aplicadas de una forma sistemática a cualquier paciente con sepsis grave. En el presente artículo hacemos un resumen de lo tratado en esa segunda parte de la Guía “Sobrevivir a la Sepsis”.
References
1.- Corwin HL, et al. EPO Critical Care Trials Group. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med. 2007 Sep 6; 357(10):965-76.
2.- Stanworth SJ, et al. Intensive Care Study of Coagulopathy (ISOC) investigators. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care. 2011;15 (2):R108. doi: 10.1186/cc10129. Epub 2011 Apr 5.
3.- Serpa Neto A, et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012 Oct 24; 308 (16):1651-9. doi: 10.1001/jama. 2012.13730.
4.- Briel M, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA. 2010 Mar 3;303 (9):865-73. doi: 10.1001/jama. 2010.218.
5.- Zhan Q, Sun B, Liang L et al. Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Crit Care Med. 2012 Feb.; 40 (2):455-60.
6.- Ayuela Azcarate, J.M.; Clau Terré, F.; Ochagavia, A.; Vicho Pereira, R. Role of echocardiography in the hemodynamic monitorization of critical patients. Med Intensiva. 2012; 36:220-32.
7.- Vincent JL. The pulmonary artery catheter. J Clin Monit Comput. 2012 Oct; 26 (5):341-5. doi: 10.1007/s10877-012-9389-2. Epub 2012 Aug 12.
8.- NICE-SUGAR Study Investigators, Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012 Sep 20;367 (12):1108-18.
9.- Preiser JC, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009 Oct;35 (10):1738-48. doi: 10.1007/s00134-009-1585-2. Epub 2009 Jul 28.
10.- Vinsonneau C, et al.; Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006 Jul 29; 368 (9533): 379-85.
11.- John S, et al. Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant. 2001 Feb;16 (2):320-7.
12.- Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis. 2004 Dec; 44 (6):1000-7.
13.- Honoré PM, et al. New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury. Blood Purif. 2012; 33 (1-3): 44-51. doi: 10.1159/000333837. Epub 2011 Dec. 15.
2.- Stanworth SJ, et al. Intensive Care Study of Coagulopathy (ISOC) investigators. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care. 2011;15 (2):R108. doi: 10.1186/cc10129. Epub 2011 Apr 5.
3.- Serpa Neto A, et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012 Oct 24; 308 (16):1651-9. doi: 10.1001/jama. 2012.13730.
4.- Briel M, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA. 2010 Mar 3;303 (9):865-73. doi: 10.1001/jama. 2010.218.
5.- Zhan Q, Sun B, Liang L et al. Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Crit Care Med. 2012 Feb.; 40 (2):455-60.
6.- Ayuela Azcarate, J.M.; Clau Terré, F.; Ochagavia, A.; Vicho Pereira, R. Role of echocardiography in the hemodynamic monitorization of critical patients. Med Intensiva. 2012; 36:220-32.
7.- Vincent JL. The pulmonary artery catheter. J Clin Monit Comput. 2012 Oct; 26 (5):341-5. doi: 10.1007/s10877-012-9389-2. Epub 2012 Aug 12.
8.- NICE-SUGAR Study Investigators, Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012 Sep 20;367 (12):1108-18.
9.- Preiser JC, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009 Oct;35 (10):1738-48. doi: 10.1007/s00134-009-1585-2. Epub 2009 Jul 28.
10.- Vinsonneau C, et al.; Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006 Jul 29; 368 (9533): 379-85.
11.- John S, et al. Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant. 2001 Feb;16 (2):320-7.
12.- Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis. 2004 Dec; 44 (6):1000-7.
13.- Honoré PM, et al. New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury. Blood Purif. 2012; 33 (1-3): 44-51. doi: 10.1159/000333837. Epub 2011 Dec. 15.
Published
2013-11-30
How to Cite
Serna Gandía, M. B. (2013). Terapias de soporte en la sepsis severa. Surviving Sepsis Campaign 2.012: Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Revista Electrónica AnestesiaR, 5(11), 1. https://doi.org/10.30445/rear.v5i11.338
Issue
Section
Critical reviews of articles
Revista Electrónica AnestesiaR by 